Alnylam Pharmaceuticals, Inc. (ALNY): Shares Outstanding
132.38M
As of 2025-12-31
133.73M
As of 2026-06-30
+2.2%
3-year compound annual growth
+2.6%
5-year compound annual growth
+4.5%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 132.38M | +2.4% | 2026-02-12, Balance as of period end |
| 2024-12-31 | 129.29M | +2.8% | 2026-02-12, Balance as of period end |
| 2023-12-31 | 125.79M | +1.5% | 2025-02-13, Balance as of period end |
| 2022-12-31 | 123.92M | +3.1% | 2024-02-15, Balance as of period end |
| 2021-12-31 | 120.18M | +3.2% | 2023-02-23, Balance as of period end |
| 2020-12-31 | 116.43M | +3.8% | 2022-02-10, Balance as of period end |
| 2019-12-31 | 112.19M | +10.9% | 2021-02-11, Balance as of period end |
| 2018-12-31 | 101.18M | +1.5% | 2020-02-13, Balance as of period end |
| 2017-12-31 | 99.67M | +16.0% | 2019-02-14, Balance as of period end |
| 2016-12-31 | 85.94M | +1.0% | 2018-02-15, Balance as of period end |
| 2015-12-31 | 85.09M | +10.2% | 2017-02-15, Balance as of period end |
| 2014-12-31 | 77.20M | +21.1% | 2016-02-12, Balance as of period end |
| 2013-12-31 | 63.74M | +21.4% | 2015-02-13, Balance as of period end |
| 2012-12-31 | 52.49M | +22.9% | 2014-02-20, Balance as of period end |
| 2011-12-31 | 42.72M | +0.9% | 2013-02-19, Balance as of period end |
| 2010-12-31 | 42.34M | +1.2% | 2012-02-13, Balance as of period end |
| 2009-12-31 | 41.84M | n/a | 2011-02-18, Balance as of period end |